cbdMD (NYSEAMERICAN:YCBD) Trading Down 1.2%

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s stock price dropped 1.2% on Wednesday . The company traded as low as $0.46 and last traded at $0.47. Approximately 25,639 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 183,599 shares. The stock had previously closed at $0.48.

cbdMD Stock Performance

The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.61 and a current ratio of 1.07. The stock has a market cap of $1.82 million, a price-to-earnings ratio of -0.04 and a beta of 2.01.

cbdMD (NYSEAMERICAN:YCBD) last issued its earnings results on Wednesday, May 15th. The company reported ($1.35) earnings per share (EPS) for the quarter. The firm had revenue of $4.82 million during the quarter. cbdMD had a negative net margin of 102.25% and a negative return on equity of 193.04%.

Institutional Investors Weigh In On cbdMD

A hedge fund recently raised its stake in cbdMD stock. AXS Investments LLC lifted its position in cbdMD, Inc. (NYSEAMERICAN:YCBD) by 42.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 91,204 shares of the company’s stock after buying an additional 27,017 shares during the quarter. AXS Investments LLC owned approximately 2.99% of cbdMD worth $95,000 at the end of the most recent quarter. 7.18% of the stock is owned by institutional investors and hedge funds.

About cbdMD

cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.